There are few reports on abdominal compartment syndrome that are caused by ovarian hyperstimulation syndrome (OHSS). Here, a case of a 29 year old woman is reported in which intravesical pressure measurement was useful in the management of severe OHSS that had been complicated by abdominal compartment syndrome. The 
| INTRODUCTION
Ovarian hyperstimulation syndrome (OHSS) is primarily an iatrogenic disease that is characterized by an exaggerated response to ovulation induction therapy.
1 This iatrogenic complication results from a loss of control of ovarian stimulation and can occur with any agent that is used to induce ovulation. [1] [2] [3] [4] Ovarian hyperstimulation syndrome consists of a variety of symptoms and signs, including ovarian enlargement, thirdspace fluid collection, hemoconcentration, pleural effusion, ascites, and abdominal discomfort subsequent to increased vascular permeability. 1, 2, 5 The treatment of OHSS usually requires i.v. fluid management to reduce the volume of ascitic fluid and to reverse hemoconcentration in order to improve the urinary output because a patient's condition depends on the retention of fluid in the third space, 1,2 while i.v. albumin also is used to reverse low serum albumin levels and to maintain urinary output.
1
It has been reported that the increase in intra-abdominal pressure (IAP) that is associated with OHSS exacerbates its symptoms. 6 It is also known that abdominal compartment syndrome (ACS) may be caused by increased IAP due to severe ascites in emergency care and general surgery settings. Increased pressure in the abdominal cavity can lead to compromised organ perfusion, similar to the compartment syndrome in limbs, which is a potentially life-threatening condition. 7, 8 However, there are only a few reports of OHSS that is complicated with ACS. 3, 6, 9 Here, a case is reported in which intravesical pressure measurement was useful in the management of a patient who was diagnosed with severe OHSS that was complicated with ACS.
| CASE REPORT
A 29 year old nulliparous woman with a history of ovulation disorder was diagnosed as having primary infertility at her first visit. She failed to conceive despite receiving multiple courses of clomiphene citrate. Thus, the ovulation stimulation agent was switched from clomiphene to daily human menopausal gonadotropin (hMG) (basal luteinizing hormone, Furthermore, she began to experience dyspnea and her IAP, which was measured indirectly based on the intravesical pressure, was found to be significantly elevated (25 mm Hg).
Ultrasound-guided paracentesis was performed and 2000 mL of ascitic fluid was drained. Following a 14 mm Hg decrease in intravesical pressure, the patient's urinary volume increased from 20-30 mL/h to ~150 mL/h. Finally, after the draining of 6000 mL of ascitic fluid, the patient's intravesical pressure dropped to 6 mm Hg and her urinary volume was maintained at 100-150 mL/h ( Figure 3 ). Heparin was administered the following day because her laboratory data revealed that her D-dimer level had risen to 3.9 μg/mL; however, a computed tomography scan revealed no thromboembolic event and her hematocrit level remained at 32.8%. The patient's ovaries were normally sized at the 18th gestational week. Her condition remained favorable as the pregnancy progressed.
The onset of labor occurred at 39 weeks and 3 days of pregnancy and she gave birth via natural vaginal delivery to a girl who weighed 3080 g.
| DISCUSSION
Due to the widespread availability and use of assisted fertility techniques, the incidence of OHSS has increased steadily since the first case was reported in 1943. 3 Recently, several treatment modalities, including the administration of gonadotropin-releasing hormone antagonists, have been used to decrease the incidence of moderate OHSS, which is estimated to occur in 0.6%-2.5% of patients who undergo assisted fertility treatment. The severe form occurs in 0.1%-1%
of in vitro fertilization cycles. [10] [11] [12] [13] [14] Ovarian hyperstimulation syndrome is a significant complication in reproductive medicine because the disease is a purely iatrogenic disorder that results from uncontrolled ovarian stimulation due to exogenous means of ovulation induction.
In the most severe cases, OHSS is potentially life-threatening as patients can suffer from thrombosis, renal insufficiency, and respiratory failure.
15,16
Ovarian hyperstimulation syndrome has been reported to cause the overexpression of vascular endothelial growth factor (VEGF) from the ovaries and to promote angiogenesis and vascular hyperpermeability. 1, 14 It is also reported that hCG increases VEGF expression in human granulose cells and raises serum VEGF concentrations. 15 Vascular endothelial growth factor is an angiogenic cytokine, which is a potent stimulator of the vascular endothelium and appears to play an integral role in follicular growth, corpus luteum function, and ovarian angiogenesis. 14 Recent studies also indicate that VEGF levels correlate with the severity of OHSS. 1 High intra-ovarian renin angiotensin system activity is another pathophysiological mechanism that has been implicated in OHSS. 14 The ovarian renin angiotensin system is involved in regulating vascular permeability, angiogenesis, endothelial proliferation, and prostaglandin release. 14 Aboulghar and Mansour reported the first classification of OHSS that combined both laboratory and clinical findings. 17 Although various disease severity classifications have been proposed, OHSS traditionally has been classified as "mild," "moderate," or "severe." 17, 18 Severe OHSS, which requires hospitalization, is characterized by the presence of vomiting (sometimes uncontrollable), dyspnea, accumulation of fluid in the third space with hydrothorax, and/or tense ascites (with pain) and evidence of intravascular fluid loss, hypovolemia with hemoconcentration, electrolyte imbalance, oliguria, and/or hepatorenal failure, with an ovary diameter of >12 cm. 17 The patient in the present study was diagnosed with severe OHSS according to that classification. Ovarian hyperstimulation syndrome is also classified, based on the timing of its manifestation, as "early" or "late." 14 Early OHSS occurs within 9 days of hCG treatment, which is used as an ovulatory trigger, and reflects the effect of exogenous hCG.
14 Late OHSS occurs after >10 days of hCG treatment and reflects the effect of endogenous hCG that is being produced by the establishment of pregnancy. 14 In the present case, the patient was consid- "Abdominal compartment syndrome" is defined as the combination of an IAP of >20 mm Hg and a new organ dysfunction. 8, 19 Various organ systems are directly or indirectly influenced by intraabdominal hypertension. For example, acute liver dysfunction can occur due to liver cell damage, mesenteric ischemia can occur due to a disturbance of mucosal microperfusion, and renal dysfunction can occur as a result of renal vein compression. The normal IAP of 5-7 mm Hg can increase due to various factors, such as abdominal surgery, ileus, intra-abdominal hemorrhage, or ascites (as occurred in the present case). 7, 8 Respiration can be impaired by the elevation of the diaphragm because the increased IAP reduces the functional residual capacity of the lung. 8 Furthermore, preloading of the heart can decrease due to compression of the renal and mesenteric veins. It is reported that oliguria occurs due to renal function disorder at an IAP of 10 mm Hg and that the vascular resistance of the renal vessels increases by ≤500%
at IAP values of >20 mm Hg. 8 Furthermore, intravesical measurement has been reported to be the most accurate method for evaluating IAP. 19 In the present case, the patient's intravesical pressure increased to 25 mm Hg at the time of oliguria. The draining of the ascitic fluid resulted in a decrease in the IAP, which allowed the urinary volume to improve and prevented the progress of ACS, thereby avoiding an artificial abortion.
Recently, concentrated ascitic reinfusion therapy has been reported to be an effective method to supplement the albumin that is removed by paracentesis. [20] [21] [22] However, this method was not able to be chosen in the present case because the decline in albumin was slight at the time of the paracentesis, the laboratory data were atypical, and paracentesis was urgently required at night.
In conclusion, intravesical measurement was a useful method for monitoring and indirectly evaluating the IAP of a patient with OHSS when the initial care failed.
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